Ligand · ULJ
ULJ · 5-amino-1-[(4-bromo-2-fluorophenyl)methyl]-N-(2,5-dimethoxyphenyl)-1H-1,2,3-triazole-4-carboxamide
ULJ, 5-amino-1-[(4-bromo-2-fluorophenyl)methyl]-N-(2,5-dimethoxyphenyl)-1H-1,2,3-triazole-4-carboxamide (C18 H17 Br F N5 O3, 450.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- ULJ
- Formula
- C18 H17 Br F N5 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
ULJ in 2 structures; the first of them:
- 6X2J · Structure of human TRPA1 in complex with agonist GNE551 · ULJ A1101 · binds SER887, LEU936, ALA939, GLN940, SER943, PHE947, ILE803, LEU807 and 7 more
- 6X2J · Structure of human TRPA1 in complex with agonist GNE551 · ULJ A1101 · binds SER887, LEU936, ALA939, GLN940, SER943, PHE947, ILE803, LEU807 and 7 more
Residues it binds most
LEU 8, ALA 8, PHE 8, SER 8, ILE 8, GLN 8, MET 8, TYR 8 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.